Clinical Trial Update: Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ketorolac for analgesia after autologous breast reconstruction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Toradol (ketorolac) (ketorolac)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Breast Cancer Female | Phase 4 | Status: WITHDRAWN